News
ImmunityBio, Inc. (NASDAQ: IBRX) today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has ...
Stem cells in rats and mice have been mobilized to form new muscle tissue "in situ" (i.e., in the body), possibly paving the way for similar treatment in people with damaged muscle regions.
Joseph Jacob, MD, discusses the promising impact of TAR-200.
Hosted on MSN9mon
Scientists Develop Lab-Grown Muscle Stem Cells for Advanced Regenerative Therapies - MSNSatellite cells are muscle stem cells responsible for muscle growth and regeneration in the postnatal stages. While these cells could significantly improve the success rates of experimental cell ...
Hosted on MSN6mon
BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide - MSNIn 2022, over 600,000 people across the world were diagnosed with bladder cancer, a 7.1% increase from 2020, putting their life plans on hold to receive standard of care treatments that are not ...
Submission is based on the ongoing QUILT 3.032 study in which 100 patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer with carcinoma in situ (NMIBC CIS ...
A phase 1/2 study of EG-70 (detalimogene voraplasmid) intravesical monotherapy for patients with BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ. Christine Tosone , James C.
The stages of non muscle invasive bladder cancer. Doctors diagnose the stage of your bladder cancer by looking at how far tumours have grown into the bladder. This is called the T stage. There are 3 T ...
Investigators enrolled 171 patients (81% male with a median age of 72) with non–muscle-invasive bladder cancer who didn't respond well to BCG treatment from clinical locations across the country.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results